Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203970 · ClinicalTrials.gov registry record
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
A clinical trial of Thrombosis, sponsored by University of Chicago.
- Active
- Registry status
- 645
- Enrollment target
- 1
- Study location
NCT00203970 is a study of Thrombosis that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 645 participants, above the 447-participant average among 28 other Thrombosis trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00203970, a study of Thrombosis, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 645 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to gain insight into the way in which physicians adopt new practice techniques. In particular, we are interested in how medical innovations diffuse throughout social networks. We wish to examine the diffusion of Low Molecular Weight Heparin (LMWH) use for Deep Vein Thrombosis (DVT) throughout the social network of general internal medicine interns, residents, and attendings at the University of Chicago Hospital. In numerous clinical trials, LMWH has been demonstrated to be as effective as unfractionated heparin as a bridge to long-term anticoagulation therapy with Coumadin, with the added benefit of early discharge from the hospital with easy dosing, no need for monitoring, and home therapy. A DVT critical pathway was established at the U of C in 1998, and LMWH was used off-label for that purpose beginning in 1997. However, it is unclear how quickly the use of LMWH was adopted by the physicians on the general medicine services, or whether there exists a pattern for this adoption.
Conditions Studied
Interventions
- BEHAVIORAL Observation
Study Locations (1)
Illinois
- The University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 645 participants |
| Start Date | 2001-02 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203970
The ClinicalTrials.gov registry entry for NCT00203970 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 645 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 447-participant average among 28 other Thrombosis trials with a reported enrollment target (44% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT00203970 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00203970 about?
NCT00203970 is a clinical study titled "Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services". The purpose of this research is to gain insight into the way in which physicians adopt new practice techniques. In particular, we are interested in how medical innovations diffuse throughout social networks. We wish to examine the diffusion of Low Molecular Weight Heparin (LMWH) use for Deep Vein Th...
What is the current status of trial NCT00203970?
This trial is currently active not recruiting. The enrollment target is 645 participants. The study started on 2001-02. Estimated completion is 2027-01.
What conditions does trial NCT00203970 study?
This clinical trial studies the following conditions: Thrombosis.
What interventions are being tested in trial NCT00203970?
The interventions under investigation include: Observation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00203970?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00203970 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
-
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.